ProShare Advisors LLC

Position in ORIC — Oric Pharmaceuticals, Inc.

CIK 1357955 BETHESDA, MD

Position in ORIC

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$142,717

-$35,663 QoQ

Shares Held

13,178

-6.4% QoQ

Ownership

0.013%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#129

of 179 holders

Holding Since

Dec 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ProShare Advisors LLC holds $336,334,656 across 174 Biotechnology names. ORIC ranks #123 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	287,847	$142,982,240
2	REGN	Regeneron Pharmaceuticals, Inc.	119,240	$74,350,909
3	ALNY	Alnylam Pharmaceuticals, Inc.	128,514	$38,686,569
4	INCY	Incyte Corp	48,152	$5,458,510
5	MRNA	Moderna, Inc.	70,621	$4,945,588
6	CYTK	Cytokinetics Inc	27,121	$2,310,437
7	TECH	BIO-TECHNE Corp	30,597	$2,161,678
8	KRYS	Krystal Biotech, Inc.	4,760	$1,769,149

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$142,717	13,178	-6.4%	Shares	Sole	2026-08-11
2026-03-31	$178,380	14,079	-14.1%	Shares	Sole	2026-04-27
2025-12-31	$134,086	16,392	+22.5%	Shares	Sole	2026-02-06
2025-09-30	$160,596	13,383	+12.9%	Shares	Sole	2025-11-06
2025-06-30	$120,338	11,856	-28.3%	Shares	Sole	2025-08-07
2025-03-31	$92,242	16,531	-20.1%	Shares	Sole	2025-05-08
2024-12-31	$166,911	20,683	+30.9%	Shares	Sole	2025-02-14
2024-09-30	$161,970	15,802	+34.7%	Shares	Sole	2024-11-14
2024-03-31	$161,328	11,733	-5.7%	Shares	Sole	2024-05-08
2021-12-31	$182,970	12,447	-0.0%	Shares	Sole	2022-02-08
2021-09-30	$260,308	12,449	-13.1%	Shares	Sole	2021-11-12
2021-06-30	$253,285	14,318	+28.6%	Shares	Sole	2021-08-13
2021-03-31	$272,709	11,131	+5.3%	Shares	Sole	2021-05-14
2020-12-31	$357,760	10,569	—	Shares	Sole	2021-02-09
No filing history on record for this holder in this stock.